Close

Sangamo Biosciences (SGMO) Tops Q1 EPS by 6c

April 22, 2015 4:13 PM EDT

Sangamo Biosciences (NASDAQ: SGMO) reported Q1 EPS of ($0.08), $0.06 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $13.5 million versus the consensus estimate of $12.5 million.

For earnings history and earnings-related data on Sangamo Biosciences (SGMO) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings